Does non-selection of innovative pharmaceutical firms hurt pride of multinational drug companies?

Published: 2012-06-25 07:00:00

Updated: 2012-06-25 07:00:00

When the government announced a list of 43 innovative pharmaceutical firms including Otsuka Korea on Monday, the KRPIA has expressed its deep regret over the government’s failure to include their other nine candidates.

Industry officials said that the pride of the U.S.- and Europe-based KRPIA ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK